Cargando…
Blockade of Mbd2 by siRNA-loaded liposomes protects mice against OVA-induced allergic airway inflammation via repressing M2 macrophage production
OBJECTIVE: To address the role of methyl-CpG-binding domain 2 (MBD2) in the pathogenesis of asthma and its potential as a target for the asthmatic therapy. METHODS: Studies were conducted in asthmatic patients and macrophage-specific Mbd2 knockout mice to dissect the role of MBD2 in asthma pathogene...
Autores principales: | Wu, Guo-Rao, Zhou, Min, Wang, Yi, Zhou, Qing, Zhang, Lei, He, Long, Zhang, Shu, Yu, Qilin, Xu, Yongjian, Zhao, Jianping, Xiong, Weining, Wang, Cong-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453648/ https://www.ncbi.nlm.nih.gov/pubmed/36090987 http://dx.doi.org/10.3389/fimmu.2022.930103 |
Ejemplares similares
-
Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis
por: Pan, Ting, et al.
Publicado: (2021) -
MBD2 facilitates tumor metastasis by mitigating DDB2 expression
por: Zhang, Lei, et al.
Publicado: (2023) -
MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program
por: Wang, Yi, et al.
Publicado: (2021) -
Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis
por: Mou, Yong, et al.
Publicado: (2022) -
Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition
por: Wang, Qi, et al.
Publicado: (2021)